Greenstreet Yvonne

Chief Executive Officer, DirectorALNYLAM PHARMACEUTICALS, INC. (ALNY) · full profile →Form 4 · filed Mar 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$948K
Net Open-Market Flow
-$948K
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)973$323.84$315K96K
Mar 4, 2026Sell(S)444$323.01$143K97K
Mar 4, 2026Sell(S)368$321.82$118K98K
Mar 4, 2026Sell(S)274$320.81$88K98K
Mar 4, 2026Sell(S)265$325.67$86K96K
Mar 4, 2026Sell(S)135$319.03$43K98K
Mar 4, 2026Sell(S)345$324.88$112K96K
Mar 4, 2026Sell(S)129$320.01$41K98K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001735276-26-000062) within minutes of acceptance. Every field above traces to the original document. Verify it directly: